Allspring Global Investments
KRYS icon

Allspring Global Investments’s Krystal Biotech KRYS Stock Holding History

Allspring Global Investments’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$641K Buy
2,475
+241
+11% +$64.1K ﹤0.01% 1321
2025
Q4 		$552K Buy
2,234
+185
+9% +$38.9K ﹤0.01% 1347
2025
Q3 		$368K Sell
2,049
-19
-0.9% -$2.84K ﹤0.01% 1424
2025
Q2 		$287K Sell
2,068
-3,112
-60% -$457K ﹤0.01% 1482
2025
Q1 		$904K Sell
5,180
-24,597
-83% -$4.14M ﹤0.01% 1281
2024
Q4 		$4.66M Sell
29,777
-81,928
-73% -$14.5M 0.01% 951
2024
Q3 		$20.3M Sell
111,705
-64,741
-37% -$12.5M 0.03% 558
2024
Q2 		$32.4M Buy
176,446
+18,021
+11% +$3.03M 0.05% 418
2024
Q1 		$28.2M Buy
158,425
+99,101
+167% +$13.8M 0.04% 479
2023
Q4 		$7.36M Buy
59,324
+4,588
+8% +$509K 0.01% 834
2023
Q3 		$6.35M Buy
54,736
+53,606
+4,744% +$6.54M 0.01% 889
2023
Q2 		$133K Buy
1,130
+29
+3% +$2.96K ﹤0.01% 1956
2023
Q1 		$88.1K Buy
1,101
+140
+15% +$11K ﹤0.01% 2093
2022
Q4 		$76.1K Sell
961
-20
-2% -$1.48K ﹤0.01% 2180
2022
Q3 		$68K Buy
981
+709
+261% +$51.2K ﹤0.01% 2231
2022
Q2 		$17K Sell
272
-3,388
-93% -$211K ﹤0.01% 2518
2022
Q1 		$243K Buy
3,660
+376
+11% +$23.5K ﹤0.01% 2507
2021
Q4 		$229K Buy
+3,284
New +$191K ﹤0.01% 2602

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments's KRYS Position: Q1 2026 in Review

Allspring Global Investments increased its Krystal Biotech (KRYS) stake by 11% in Q1 2026, buying an estimated $64.1K and bringing the position to 2,475 shares worth $641K. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

Allspring Global Investments first reported a position in KRYS in Q4 2021 and has held it in 18 quarters since. The position peaked at $32.4M in Q2 2024. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Allspring Global Investments held 2,475 shares of Krystal Biotech worth $641K as of Q1 2026.
  • Allspring Global Investments bought 241 Krystal Biotech shares in Q1 2026, an estimated $64.1K.
  • Krystal Biotech made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1321 holding.
  • Allspring Global Investments first reported a position in Krystal Biotech in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Krystal Biotech position peaked at $32.4M in Q2 2024.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.